FR2874825B1 - Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale - Google Patents

Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale

Info

Publication number
FR2874825B1
FR2874825B1 FR0409528A FR0409528A FR2874825B1 FR 2874825 B1 FR2874825 B1 FR 2874825B1 FR 0409528 A FR0409528 A FR 0409528A FR 0409528 A FR0409528 A FR 0409528A FR 2874825 B1 FR2874825 B1 FR 2874825B1
Authority
FR
France
Prior art keywords
vaginal flora
prebiotic oligosaccharides
beneficial prebiotic
beneficial
oligosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0409528A
Other languages
English (en)
Other versions
FR2874825A1 (fr
Inventor
Francois Marie Bernard Paul
Virginie Severine Mar Rousseau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENIBIO SARL
Original Assignee
GENIBIO SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GENIBIO SARL filed Critical GENIBIO SARL
Priority to FR0409528A priority Critical patent/FR2874825B1/fr
Priority to PCT/FR2005/002211 priority patent/WO2006030100A1/fr
Publication of FR2874825A1 publication Critical patent/FR2874825A1/fr
Application granted granted Critical
Publication of FR2874825B1 publication Critical patent/FR2874825B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0409528A 2004-09-08 2004-09-08 Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale Expired - Lifetime FR2874825B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0409528A FR2874825B1 (fr) 2004-09-08 2004-09-08 Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
PCT/FR2005/002211 WO2006030100A1 (fr) 2004-09-08 2005-09-06 Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409528A FR2874825B1 (fr) 2004-09-08 2004-09-08 Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale

Publications (2)

Publication Number Publication Date
FR2874825A1 FR2874825A1 (fr) 2006-03-10
FR2874825B1 true FR2874825B1 (fr) 2006-12-08

Family

ID=34948336

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0409528A Expired - Lifetime FR2874825B1 (fr) 2004-09-08 2004-09-08 Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale

Country Status (2)

Country Link
FR (1) FR2874825B1 (fr)
WO (1) WO2006030100A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2748651C2 (ru) * 2017-02-28 2021-05-28 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
US11590176B2 (en) 2012-02-29 2023-02-28 Johnson & Johnson Consumer Inc. Compositions of microbiota and methods related thereto

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2933617B1 (fr) * 2008-07-10 2010-09-17 Alliospharma Compositions visant a favoriser le developpement et la croissance d'une microflore vaginale benefique
IT1398279B1 (it) * 2009-06-25 2013-02-22 Bsd Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale
US9011909B2 (en) 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
CN104105471B (zh) * 2012-02-14 2018-03-13 宝洁公司 皮肤共生益生元剂和包含其的组合物的局部使用
EP3117827B1 (fr) 2014-03-13 2021-11-03 Singapore Ze&Z International Pte. Ltd. Composition vaginale et son utilisation
WO2016007778A1 (fr) 2014-07-09 2016-01-14 Midori Usa, Inc. Compositions d'oligosaccharides et leurs procédés de production
CA2964480A1 (fr) 2014-10-31 2016-05-06 Whole Biome Inc. Procedes et compositions se rapportant a un traitement microbien et au diagnostic de troubles
CA2973617A1 (fr) * 2015-01-26 2016-08-04 Kaleido Biosciences, Inc. Compositions therapeutiques de gylcane et procedes associes
EP3964234A1 (fr) 2015-04-23 2022-03-09 Kaleido Biosciences, Inc. Agents thérapeutiques de glycanes et procédés de traitement
CA2994430A1 (fr) * 2015-08-25 2017-03-02 Kaleido Biosciences, Inc. Compositions de glycane et leurs utilisations
RU2709464C2 (ru) 2015-09-29 2019-12-18 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
US20180256615A1 (en) * 2015-09-29 2018-09-13 Kimberly-Clark Worldwide, Inc. Composition for maintaining lactobacillus dominance
WO2019046646A1 (fr) 2017-08-30 2019-03-07 Whole Biome Inc. Methodes et compositions pour le traitement de troubles associés au microbiome
JP7811843B2 (ja) 2018-07-19 2026-02-06 ペンデュラム セラピューティクス， インコーポレイテッド 微生物生着のための方法および組成物
FR3097436B1 (fr) * 2019-06-24 2023-10-13 Oreal Composition cosmétique comprenant une association d’au moins un oligosaccharide et/ou polysaccharide associé à un monosaccharide mannose
FR3118711A1 (fr) * 2021-01-12 2022-07-15 Beghin Meiji Methode cosmetique et composition a base de fructo-oligosaccharides a chaine courte
WO2022152762A1 (fr) * 2021-01-12 2022-07-21 Beghin Meiji Methode cosmetique et composition a base de fructooligosaccharides a chaine courte et d'un amidon natif
FR3129083B1 (fr) * 2021-11-18 2024-09-27 Beghin Meiji Methode cosmetique et composition a base de fructo-oligosaccharides a chaine courte
EP4272727A1 (fr) * 2022-05-04 2023-11-08 Ecareyou Innovation, S.L. Produit permettant d'améliorer la fertilité
CN121379833B (zh) * 2025-12-19 2026-03-24 齐鲁工业大学(山东省科学院) 一株出芽短梗霉Cy28及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
EP0710484A3 (fr) * 1994-10-07 1996-10-23 Univ Illinois Mélange de alpha-D-glucopyranosyl-(1-6)-alpha-D glucopyranose comme agent antitumoral
EP0881905A1 (fr) * 1996-02-14 1998-12-09 The Procter & Gamble Company Compositions pour le traitement de troubles urogenitaux et intestinaux contenant une substance derivee d'especes de plantes de la famille des ericaceae et un facteur de croissance de bacteries d'acide lactique
JP2003137790A (ja) * 2001-11-01 2003-05-14 Mie Kariyou Kk β−２，１（β２→β１）結合連鎖フラクトースオリゴマーを含有するフラクトオリゴ糖を有効成分とする医薬

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590176B2 (en) 2012-02-29 2023-02-28 Johnson & Johnson Consumer Inc. Compositions of microbiota and methods related thereto
RU2748651C2 (ru) * 2017-02-28 2021-05-28 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры

Also Published As

Publication number Publication date
WO2006030100A1 (fr) 2006-03-23
FR2874825A1 (fr) 2006-03-10

Similar Documents

Publication Publication Date Title
EP2101931A4 (fr) Précurseurs pour la formation de séléniure de cuivre, de séléniure d'indium, de diséléniure de cuivre indium, et/ou de films de diséléniure de cuivre indium gallium
EP1744702A4 (fr) Ensemble occlusif urétral pour prévenir l'incontinence urinaire
EP1824628A4 (fr) Plaquette d'insertion
EP2068864A4 (fr) Utilisations thérapeutiques d'urolithines
EP1790339A4 (fr) Composition pour la prévention de la survenue d'un événement cardiovasculaire
EP1716578A4 (fr) Pate metallique nanometrique pour interconnexion et procede d'utilisation
EP2032566A4 (fr) Dérivés d'azétidine comme inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase
EP2055268A4 (fr) Moulage d'os, charge d'os et procede de production d'une charge d'os
EP2087435A4 (fr) Invocation de services d'application
EP2012803A4 (fr) Compositions polymères et procédés de production et d'utilisation de ces compositions
EP1762234A4 (fr) Activateur d'ampk
EP2244700A4 (fr) Souris knockout pour molécule d'interaction stromale et ses utilisations
EP1746141A4 (fr) Composition d' epaississement
EP1901733A4 (fr) Utilisation d'huperzine pour des pathologies
EP1805663A4 (fr) Options de co-paiement pour l'echange de points pour grands voyageurs selon des regles
EP2039020A4 (fr) Procédé d'utilisation efficace de ressources dans une transmission sur liaison montante
FR2874825A1 (fr) Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
FR2871155B1 (fr) Utilisation de polysaccharides particuliers pour l'adjuvantation de matieres minerales
FR2875971B1 (fr) Convertisseur alternatif-continu pour l'aeronautique
FR2898872B1 (fr) Panneau d'equipement pour satellite artificiel.
EP1974370A4 (fr) Composition pour microgravure et son procede d'utilisation
EP1861427A4 (fr) Compositions d'amidon agglomerees
FR2903040B1 (fr) Presse vibrante pour la production d'elements de construction
EP1714656A4 (fr) Preparation de l'ed-71
FI20060247L (fi) Bakteeri-itiöiden muodostumisen estäminen kartonkikoneen hylkysysteemissä

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20